Favourites   Have ideas?

Positive:   Cannabis ↓8.54   Healthcare ↓7.23   Disease: Cardiovascular ↓7.23 «See more»   Biopharma ↑6.57   Manufacturing  ↑8.99   Equipment ↑8.99

Negative:   Bad infrastructure  ↓6.16


Disease: Oncology segment

ARAY TR» TW» GGL» QAccuray Incorporated - Common Stock + My List 8.99% 8.99% 0 + Disease: Oncology, Medicine, Equipment, Manufacturing


Last highlighted: $ARAY 📜 Accuray Incorporated filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits https://t.co/48zqtD0zRx #healthcare
ARVN TR» TW» GGL» QArvinas, Inc. - Common Stock + My List -5.51% up -7.16% 1.65 + Disease: Neuropsychiatric, Medicine, Disease: Oncology


Last highlighted: @BioValues Protein degrader tech being explored for Alzheimer's by $ARVN $CCCC Interestingly $CCCC has a collaboration w/ $BIIB since Jan 2019 (still active & ongoing per last 10-Q) https://t.co/vJ5Qqj2IPp
AVEO TR» TW» GGL» SAVEO Pharmaceuticals, Inc. - Common Stock + My List 5.74% down 10.12% -4.38 + Medicine, Disease: Oncology, Cancer fight

CTMX TR» TW» GGL» QCytomX Therapeutics, Inc. - Common Stock + My List -6.16% up -12.58% 6.42 + Biopharma, Cancer fight, Disease: Oncology
- Bad infrastructure
IMTX TR» TW» GGL» SImmatics N.V. - Ordinary Shares + My List 1.88% up -8.41% 10.29 + Immunology, Cancer fight, Disease: Oncology, Medicine

ITOS TR» TW» GGL» GiTeos Therapeutics, Inc. - Common Stock + My List 34.24% up 34.15% 0.090000000000003 + Cancer fight, Biopharma, Disease: Oncology, Immunology, Medicine


Last highlighted: $ITOS 📜 iTeos Therapeutics, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement https://t.co/fsH6i8bthL 15s delayed.
KPTI TR» TW» GGL» QKaryopharm Therapeutics Inc. - Common Stock + My List 6% down 7.5% -1.5 + Cancer fight, Disease: Oncology, Pharmaceutical , Medicine

MOR TR» TW» GGL» QMorphoSys AG - American Depositary Shares + My List 5.23% down 7.58% -2.35 + Biopharma, Medicine, Disease: Oncology, Immunology, Cancer fight

NCNA TR» TW» GGL» QNuCana plc - American Depositary Shares + My List -3.77% up -7.23% 3.46 + Cancer fight, Disease: Oncology, Medicine

PDSB TR» TW» GGL» SPDS Biotechnology Corporation - Common Stock + My List -5.59% up -7.63% 2.04 + Biotechnology, Immunology, Cancer fight, Disease: Oncology, Medicine


Last highlighted: RT @EdgarInsider: FORM 8-K [Press/News Current Report] recently SEC filed. $PDSB $EDGE PDS Biotechnology Corp https://t.co/FKxSQ3btJT
QTRX TR» TW» GGL» GQuanterix Corporation - Common Stock + My List -7.23% -7.23% 0 + Healthcare, Biology, Disease: Infectious, Disease: Cardiovascular, Cancer fight, Disease: Oncology


Last highlighted: $QTRX 📜 Quanterix Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits https://t.co/8tiTtutDoW #capitalgoods
TCON TR» TW» GGL» STRACON Pharmaceuticals, Inc. - Common Stock + My List -7.02% -7.02% 0 + Pharmaceutical , Cancer fight, Medicine, Biopharma, Disease: Oncology

TLC TR» TW» GGL» GTaiwan Liposome Company, Ltd. - American Depositary Shares + My List 2.57% down 7.16% -4.59 + Country: Taiwan, Medicine, Pain fight, Disease: Oncology, Disease: Infectious, Ophthalmology

BCTX TR» TW» GGL» SBriaCell Therapeutics Corp. - Common Shares + My List -7.59% down -6.77% -0.82 + Cancer fight, Immunology, Medicine, Disease: Oncology


Last highlighted: $BCTX / BriaCell Therapeutics files form 6-K https://t.co/617kvcWKYm
ENVB TR» TW» GGL» SEnveric Biosciences, Inc. - Common Stock + My List -8.54% up -9.76% 1.22 + Biotechnology, Cancer fight, Medicine, Cannabis, Disease: Oncology


Last highlighted: $ENVB 8-K Enveric Biosciences (8 Jun, 2:25pm) 📰 Regulation FD Disclosure; Financial Statements and Exhibits https://t.co/cn8oMiFBRC #ENVB #8K #EnvericBiosciences #News
PPBT TR» TW» GGL» SPurple Biotech Ltd. - American Depositary Shares + My List 5.84% down 9.14% -3.3 + Country: Israel, Cancer fight, Disease: Oncology



We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.